Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Arbutus Biopharma Corp (NASDAQ:ABUS)

10.50
Delayed Data
As of 3:59pm ET
 -0.33 / -3.05%
Today’s Change
10.02
Today|||52-Week Range
29.93
-30.69%
Year-to-Date

Today’s Trading

Previous close10.83
Today’s open10.78
Day’s range10.22 - 11.20
Volume193,043
Average volume (3 months)682,524
Market cap$587.1M
Dividend yield--
Data as of 3:59pm ET, 08/03/2015

Growth & Valuation

Earnings growth (last year)-95.65%
Earnings growth (this year)--
Earnings growth (next 5 years)+15.00%
Revenue growth (last year)-3.31%
P/E ratio--
Price/Sales22.17
Price/Book2.76

Competitors

 Today’s
change
Today’s
% change
PGNXProgenics Pharmaceut...-0.10-1.15%
CARACara Therapeutics In...+0.51+2.39%
OMEROmeros Corp-0.18-1.12%
PETXAratana Therapeutics...-0.24-1.36%
Data as of 4:14pm ET, 08/03/2015

Financials

Next reporting dateAugust 6, 2015
EPS forecast (this quarter)-$0.26
Annual revenue (last year)$15.0M
Annual profit (last year)-$38.8M
Net profit margin-259.73%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Mark J. Murray
Chief Operating Officer
Patrick T. Higgins
Corporate headquarters
Burnaby, British Columbia

Forecasts